Neonatal tumor necrosis factor α promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8+ T cells

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 225-237

  Green, E Allison ^a   Wong, F Susan ^a   Eshima, Koji ^a   Mora, Conchi ^a   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD154; CD8+ cells; Diabetes; NOD mice; TNF

Indexed keywords

CD40 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; DIABETES MELLITUS; DISEASE COURSE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANIMALS, NEWBORN; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFANT, NEWBORN; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034677105     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.225     Document Type: Article

References (61)

1. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
2. Bennett, S.R.M., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F.A.P. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature. 393: 478-480.
3. + T-helper cell and a T-killer cell. Nature. 393:474-478.
4. Schoenberger, S.P., R.E.M. Toes, E.I. van der Voort, R. Offringa, and C.J.M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
5. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
6. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1:155-166.
7. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791-1796.
8. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
9. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Kootan, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
10. Wang, Z., J.G. Karras, R.G. Howard, and T.L. Rothstein. 1995. Induction of Bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J. Immunol. 155:3722-3725.
11. Foy, T.M., D.M. Shepherd, F.H. Duric, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
12. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:617-620.
13. Mach, F., U. Shonbeck, G.K. Sukhova, E. Atkinson, and P. Libby. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature. 394:200-203.
14. Balasa, B., T. Krah, G. Patstone, J. Lee, R. Tisch, H.O. McDevitt, and N. Sarvetnick. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159:4620-4627.
15. Grewal, I.S., H.G. Foellmer, K.D. Grewal, J. Xu, F. Hardardottir, J.L. Baron, C.A.J. Janeway, Jr., and R.A. Flavell. 1996. Requirement for CD40 ligand in co-stimulation induction and experimental allergic encephalomyelitis. Science. 273:1864-1867.
16. Delovitch, T.L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 7:727-738.
17. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class 1 molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:3358-3360.
18. Serreze, D.V., E.H. Leiter, G.J. Christianson, D. Greiner, and D.C. Roopenian. 1994. Major histocompatibility complex class I-deficient NOD-β2mnull mice are diabetes and insulitis resistant. Diabetes. 43:505-509.
19. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1762-1769.
20. Wicker, L.S., E.H. Leiter, J.A. Todd, R.J. Renjilian, E. Peterson, P.A. Fischer, P.L. Podolin, M. Zijlstra, R. Jaenisch, and L.B. Peterson. 1994. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 43: 500-504.
21. Mora, C., F.S. Wong, C.-H. Chang, and R.A. Flavell. 1999. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J. Immunol. 162:4576-4588.
22. Shizuru, J.A., E.C. Taylor, B.A. Banks, A.K. Gregory, and C.G. Fathman. 1988. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science. 240:659-662.
23. + cells. J. Exp. Med. 166:823-832.
24. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140:52-58.
25. Kurts, C., J.F.A.P. Miller, R.M. Subramanian, F.R. Carbone, and W.R. Heath. 1998. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigen and those released during cellular destruction. J. Exp. Med. 188:409-414.
26. + T cells to cause immunopathology. J. Exp. Med. 5:763-774.
27. Held, W., H.R. MacDonald, I.L. Weissman, M.W. Hess, and C. Mueller. 1990. Genes encoding tumor necrosis factor-α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 87:2239-2243.
28. Yang, X.D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
29. Green, E., E. Eynon, and R. Flavell. 1998. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 9:733-743.
30. Chang, C.-H., S. Guerder, S.C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:167-178.
31. Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993b. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1089-1110.
32. Wong, F.S., I. Visintin, L. Wen, R.A. Flavell, and C.A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183: 67-76.
33. Kay, T.W., J.L. Parker, L.A. Stephens, H.E. Thomas, and J. Allison. 1996. RIP-beta 2-microglobulin transgene expression restores insulitis but not diabetes in beta2-microglobulin null nonobese diabetic mice. J. Immunol. 157:3688-3693.
34. Kaufman, D.L., M. Clare-Salzer, J. Tian, T. Forsthuber, G. Ting, P.A. Robinson, M.A. Atkinson, E. Sercarz, A. Tobin, and P. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:69-72.
35. Tisch, R., S. Yang, S.M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:72-75.
36. Steimle, V., L.A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency or bare lymphocyte syndrome. Cell. 75:135-146.
37. Chang, C.-H., J.D. Fontes, M. Peterlin, and R.A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.
38. Chang, C.-H., S.C. Hong, C.C. Hughes, C.A.J. Janeway, Jr., and R.A. Flavell. 1995. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7:1515-1518.
39. Chang, C.H., and R.A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767.
40. Gobin, S.J.P., A. Peijnenburg, V. Keijsers, and J. van den Elsen. 1997. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:601-611.
41. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
42. Martin, B.K., K.C. Chin, J.C. Olsen, C.A. Skinner, A. Dey, K. Ozato, and J.P.Y. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:591-600.
43. Muhlethaler-Mottet, A., W. Di Bernardino, L.A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by mterferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:157-166.
44. + T cells in major histocompatibility complex class II-deficient mice. Science. 253: 1417-1420.
45. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051-1066.
46. Williams, G.S., M. Malin, D. Vremec, C.-H. Chang, R. Boyd, C. Benoist, and D. Mathis. 1998. Mice lacking the transcription factor CIITA - a second look. Int. Immunol. 10: 1957-1967.
47. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
48. Serreze, D.V., S.A. Fleming, H.D. Chapman, S.D. Richard, E.H. Leiter, and R.M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells tor the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161:3912-3918.
49. Bachmann, M.F., B.R. Wong, R. Josien, R.M. Steinman, A. Oxenius, and Y. Choi. 1999. TRANCE (tumor necrosis factor |TNF|-related activation-induced cytokine), a TNF family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189:1025-1031.
50. + CTL response. J. Exp. Med. 183:2129-2142.
51. Borrow, P., D.F. Tough, D. Eto, A. Tishon, I.S. Grewal, J. Sprent, R.A. Flavell, and B.A. Oldstone. 1998. CD40 ligand-mediated interactions are involved in the generation of memory CD8( + ) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J. Virol. 72:7440-7449.
52. + T cell functions. J. Exp. Med. 183:2209-2218
53. Whitmire, J.K., M.K. Slifka, I.S. Grewal, R.A. Flavell, and R. Ahmed. 1996. CD40 ligand-deficient mice generate a normal cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70:8375-8381.
54. Kurts, C., W.R. Heath, F.R. Carbone, J. Allison, J.F.A.P. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self-antigens in vivo. J. Exp. Med. 184:923-930.
55. Jacob, C.O., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA. 87:968-972.
56. Grewal, I.S., K.D. Grewal, F.S. Wong, D.E. Picarella, C.A.J. Janeway, Jr., and R.A. Flavell. 1996. Local expression of transgene encoded TNF-α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184:1963-1974.
57. Cope, A.P., R.S. Liblau, X.-D. Yang, M. Congia, C. Laudanna, R.D. Schreiber, L. Probert, G. Kollias, and H.O. McDevitt. 1997. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185:1573-1584.
58. Kurts, C., F.R. Carbone, M. Krummel, K.M. Koch, J.F. Miller, and W.R. Heath. 1999. Signaling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature. 398:341-344.
59. O'Brien, B.A., B.V. Harmon, D.P. Cameron, and D.J. Allan. 1997. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes. 46:750-757.
60. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331-339.
61. Dahlén, E., K. Dawe, L. Ohlsson, and G. Hedlund. 1998. Dendritic cells and macrophages are the first and major producers of TNFα in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 160:3585-3593.